InVivo Therapeutics Holdings Corp. NVIV, a developer of
groundbreaking technologies for the treatment of spinal cord injuries
(SCI) and other neurotrauma conditions, announced today that the call
notice period for the early exercise of warrants issued to investors on
October 26, 2010, November 10, 2010 and December 3, 2010 (the “Investor
Warrants”) expired on June 3, 2013. By the expiration of the call
period, 100% of the Investor Warrants were exercised. The exercises
during the call period, coupled with warrant exercises during April
2013, raised $16.1 million gross and $15.6 million after solicitation
expenses. Approximately 11.5 million shares of common stock were issued
in connection with these warrant exercises. The combination of the
exercise of all the Investor Warrants along with the
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in